Next, we used a glioblastoma U-118 MG cell line, harboring the FIG-ROS1 fusion gene, and DS-6051b treatment dose dependently inhibited autophosphorylation of ROS1 in U-118-MG cells in vitro (Fig. 2g). This evidence concerns the gene ROS1 and glioblastoma.